Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Reported Tuberculosis in the United States, 2013

Return to Main Menu

(PDF - 191k)

Table 49. Tuberculosis Cases and Percentages by Initial Drug Regimen: Reporting Areas, 2013

Reporting Area Total
Cases		 Cases in
Persons
Alive at
Diagnosis		 Cases with Information on
Initial Drug Regimen1		 Percentage of Cases in Persons with
Initial Drug Regimen2
No. (%) IR IRZ IRZE3
United States 9,582 9,357 9,271 (99.1) (0.5) (2.4) (84.6)
 
Alabama 108 103 103 (100.0) (0.0) (3.9) (77.7)
Alaska 71 71 69 (97.2) (1.4) (0.0) (94.2)
Arizona 184 179 176 (98.3) (0.6) (1.1) (94.3)
Arkansas 72 71 70 (98.6) (1.4) (18.6) (78.6)
California 2,171 2,125 2,105 (99.1) (0.2) (1.1) (90.8)
Colorado 74 73 72 (98.6) (2.8) (2.8) (72.2)
Connecticut 62 59 59 (100.0) (0.0) (0.0) (15.3)
Delaware 19 19 19 (100.0) (0.0) (15.8) (78.9)
District of Columbia 38 38 36 (94.7) (0.0) (0.0) (100.0)
Florida 652 633 632 (99.8) (0.3) (2.2) (87.7)
Georgia 340 327 325 (99.4) (0.9) (3.1) (37.2)
Hawaii 115 114 113 (99.1) (0.0) (2.7) (89.4)
Idaho 11 11 11 (100.0) (0.0) (9.1) (45.5)
Illinois 327 321 314 (97.8) (0.6) (6.1) (84.4)
Indiana 94 90 90 (100.0) (0.0) (3.3) (95.6)
Iowa 47 47 47 (100.0) (0.0) (4.3) (89.4)
Kansas 36 36 36 (100.0) (0.0) (8.3) (88.9)
Kentucky 59 58 58 (100.0) (0.0) (0.0) (79.3)
Louisiana 139 135 135 (100.0) (1.5) (5.2) (89.6)
Maine 15 14 14 (100.0) (0.0) (14.3) (85.7)
Maryland 176 175 175 (95.5) (1.1) (4.6) (86.9)
Massachusetts 201 198 189 (99.5) (2.1) (1.1) (78.3)
Michigan 141 138 135 (97.8) (0.7) (2.2) (52.6)
Minnesota 151 150 150 (100.0) (0.0) (2.0) (88.7)
Mississippi 65 60 60 (100.0) (1.3) (10.3) (82.1)
Missouri 104 102 102 (100.0) (0.0) (3.3) (86.7)
Montana 6 6 6 (100.0) (0.0) (3.9) (81.4)
Nebraska 21 21 21 (100.0) (0.0) (4.8) (61.9)
Nevada 92 89 89 (100.0) (0.0) (2.2) (91.0)
New Hampshire 15 15 15 (100.0) (0.0) (6.7) (73.3)
New Jersey 319 314 314 (100.0) (0.3) (2.2) (89.2)
New Mexico 50 46 45 (97.8) (6.7) (2.2) (86.7)
New York State4 216 216 215 (99.5) (0.0) (3.7) (83.7)
New York City 656 650 646 (99.4) (0.2) (0.8) (89.9)
North Carolina 216 206 205 (99.5) (0.0) (1.5) (82.0)
North Dakota 12 9 9 (100.0) (0.0) (0.0) (66.7)
Ohio 148 145 145 (100.0) (0.0) (0.0) (95.2)
Oklahoma 69 67 66 (98.5) (6.1) (6.1) (80.3)
Oregon 73 73 72 (98.6) (0.0) (6.9) (81.9)
Pennsylvania 214 212 209 (98.6) (0.0) (0.0) (64.1)
Rhode Island 27 26 26 (100.0) (3.8) (0.0) (92.3)
South Carolina 112 107 106 (99.1) (0.9) (10.4) (82.1)
South Dakota 9 9 9 (100.0) (0.0) (0.0) (55.6)
Tennessee 142 136 136 (100.0) (0.0) (3.7) (80.9)
Texas 1,222 1,183 1,167 (98.6) (0.6) (2.5) (90.2)
Utah 33 33 32 (97.0) (0.0) (0.0) (93.8)
Vermont 5 5 5 (100.0) (0.0) (20.0) (60.0)
Virginia 180 173 173 (100.0) (0.0) (0.0) (94.8)
Washington 210 206 204 (99.0) (1.0) (2.9) (83.3)
West Virginia 13 13 13 (100.0) (0.0) (0.0) (69.2)
Wisconsin 50 50 48 (96.0) (2.1) (2.1) (60.4)
Wyoming 0 0 0 -- -- -- --
 
American Samoa5 2 2 2 (100.0) (0.0) (0.0) (100.0)
Fed. States of Micronesia5 130 127 127 (100.0) (0.0) (0.0) (99.2)
Guam5 48 47 47 (100.0) (0.0) (12.8) (10.6)
Marshall Islands5 153 153 153 (100.0) (0.0) (0.0) (97.4)
N. Mariana Islands5 16 16 0 (0.0) -- -- --
Puerto Rico5 50 47 47 (100.0) (1.5) (0.0) (100.0)
Republic of Palau5 6 6 6 (100.0) (0.0) (0.0) (100.0)
U.S. Virgin Islands5 2 2 2 (100.0) (0.0) (0.0) (100.0)

1 Includes persons who were alive at diagnosis and started on one or more drug.

2 Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages shown only for reporting areas with information reported for ≥75% of cases.

3 I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol. Cases with other drugs prescribed in addition to these regimens are excluded.

4 Excludes New York City.

5 Not included in U.S. totals.

Note: Excluding cases with no information on drug regimen, 53 (0.57%) persons were not started on any drugs, 2 (0.02%) were started on one drug, and 1152 (12.36%) had an initial multiple drug regimen other than IR, IRZ, or IRZE.

Top